摘要
经皮冠状动脉介入治疗术是冠心病患者血液运行重建较常用的方法,但术后可能伴有血流缓慢、心律失常及无法恢复正常血流等.故术后心肌受损是改善预后的基础.近年来的相关文献认为,中药可抑制氧自由基、缓解Ca2＋超载、调节心肌细胞本身的能量代谢,修补微血管损伤等,恢复患者的机体功能,并通过多靶点、多层面对术后心肌受损提供保护.
Percutaneous coronary artery intervention（PCI）is an important method for revascularization in patients with coronary heart disease（CHD）, however the clinical observation showed that postoperative PCI often appeared slow blood flow, reperfusion arrhythmia, or no reflux. Therefore, reducing myocardial injury after PCI is the key to improve the prognosis of patients with coronary heart disease after PCI. Studies have shown that Chinese medicine could restrain the role of oxygen free radicals, reduce the overload of intracellular Ca2＋, improve the energy metabolism of myocardial cells, repair microvascular injury, recover the patient＆#39;s body function, and provide protection for myocardial injury after PCI surgery through multi-targets and multi-levels.
出处
《国际中医中药杂志》
2017年第12期1144-1147,共4页
International Journal of Traditional Chinese Medicine
基金
常州市科学技术局科研项目（CJ20160025）
关键词
经皮冠状动脉介入治疗
手术后并发症
心肌缺血
中医药
综述
Percutaneous coronary intervention
Postoperative complications
Myocardial ischemia
Traditional Chinese medicine
Review
